Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans

Autor: Tortorici, M. Alejandra, Addetia, Amin, Seo, Albert J., Brown, Jack, Sprouse, Kaiti, Logue, Jenni, Clark, Erica, Franko, Nicholas, Chu, Helen, Veesler, David

Publikováno v: In Immunity 9 April 2024 57(4):904-911

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Persistent immune imprinting after XBB.1.5 COVID vaccination in humans.

Autor: Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA., Addetia A; Department of Biochemistry, University of Washington, Seattle, WA, USA., Seo AJ; Department of Biochemistry, University of Washington, Seattle, WA, USA., Brown J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA, USA., Logue J; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Clark E; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Franko N; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Chu H; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA.; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 30. Date of Electronic Publication: 2023 Nov 30.

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

Autor: Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA, USA., Rosen LE; Vir Biotechnology, San Francisco, CA, USA., Saliba C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Zepeda SK; Department of Biochemistry, University of Washington, Seattle, WA, USA., Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Pinto D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., VanBlargan LA; Department of Medicine, Washington University of School of Medicine, St Louis, MO, USA., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., di Iulio J; Vir Biotechnology, San Francisco, CA, USA., Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Kaiser H; Vir Biotechnology, San Francisco, CA, USA., Noack J; Vir Biotechnology, San Francisco, CA, USA., Farhat N; Vir Biotechnology, San Francisco, CA, USA., Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA., Havenar-Daughton C; Vir Biotechnology, San Francisco, CA, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA, USA., Dillen JR; Vir Biotechnology, San Francisco, CA, USA., Powell AE; Vir Biotechnology, San Francisco, CA, USA., Chen A; Vir Biotechnology, San Francisco, CA, USA., Maher C; Vir Biotechnology, San Francisco, CA, USA., Yin L; Vir Biotechnology, San Francisco, CA, USA., Sun D; Vir Biotechnology, San Francisco, CA, USA., Soriaga L; Vir Biotechnology, San Francisco, CA, USA., Bassi J; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Silacci-Fregni C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Gustafsson C; ATUM, Newark, CA, USA., Franko NM; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Logue J; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Iqbal NT; Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan., Mazzitelli I; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina., Geffner J; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina., Grifantini R; National Institute of Molecular Genetics, Milan, Italy., Chu H; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Gori A; Infectious Disease Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Riva A; Department of Biomedical and Clinical Sciences 'L.Sacco' (DIBIC), Università di Milano, Milan, Italy., Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland., Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Cippà PE; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Franzetti-Pellanda A; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Halfmann PJ; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA., Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan., Hebner C; Vir Biotechnology, San Francisco, CA, USA., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Piccoli L; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA, USA.; Howard Hughes Medical Institute, Seattle, WA, USA., Diamond MS; Department of Medicine, Washington University of School of Medicine, St Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.; Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA., Telenti A; Vir Biotechnology, San Francisco, CA, USA., Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA., Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.; National Institute of Molecular Genetics, Milan, Italy., Snell G; Vir Biotechnology, San Francisco, CA, USA. gsnell@vir.bio., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA. dveesler@uw.edu.; Howard Hughes Medical Institute, Seattle, WA, USA. dveesler@uw.edu., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio.

Publikováno v: Nature [Nature] 2022 Feb; Vol. 602 (7898), pp. 664-670. Date of Electronic Publication: 2021 Dec 23.